<DOC>
	<DOCNO>NCT01577511</DOCNO>
	<brief_summary>The main objective study identify characterize subpopulation cell invasive capacity colorectal cancer primary tumor , blood metastatic sample .</brief_summary>
	<brief_title>Invasiveness Chemoresistance Cancer Stem Cells Colon Cancer</brief_title>
	<detailed_description>Secondary objective include : - Determine intrinsic property essential dissemination chemoresistance cell capable initiate tumor - Identify `` molecular signature '' potential invasiveness chemoresistance cell initiate metastasis . - Describe evolution patient 24 month follow correlation observe cellular profile . - Enrich tumor bank institution .</detailed_description>
	<mesh_term>Colonic Neoplasms</mesh_term>
	<mesh_term>Colorectal Neoplasms</mesh_term>
	<criteria>The patient must give his/her inform sign consent The patient must insure beneficiary health insurance plan Patient adenocarcinomatype colorectal cancer : stage III diagnosis , surgical resection primary tumor propose . stage IV diagnosis , surgical resection primary tumor possibly metastasis propose . Stage IV already undergone surgical excision primary tumor , metastasectomy propose . The patient participate another study The patient exclusion period determine previous study The patient judicial protection , tutorship curatorship The patient refuse sign consent It impossible correctly inform patient Patients surgical resection primary tumor consider option PStage IV diagnosis , metastasectomy consider option Patients positive HIV , Hepatitis B Hepatitis C serology</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>invasive potential</keyword>
	<keyword>molecular characterisation circulate cell</keyword>
</DOC>